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Objectives. This study sought to determine whether left atrial
appendage stunning occurs in patients with atrial flutter and to
compare left atrial appendage function in the pericardioversion
period with that in patients with atrial fibrillation.
Background. Left atrial appendage stunning has recently been
proposed as a key mechanistic phenomenon in the etiology of
postcardioversion thromboembolic events in atrial fibrillation.
Atrial flutter is thought to be associated with a negligible risk of
thromboembolic events; therefore, anticoagulation is commonly
withheld before and after cardioversion in these patients.
Methods. Sixty-three patients with atrial flutter (n 5 19) or
atrial fibrillation (n 5 44) underwent transesophageal echocardi-
ography immediately before and after electrical cardioversion. In
addition to assessing the presence of thrombus and spontaneous
echo contrast, we measured left atrial appendage emptying veloc-
ity and calculated shear rates by pulsed wave Doppler and
two-dimensional echocardiography.
Results. Patients with atrial flutter exhibited greater left atrial
appendage flow velocities before cardioversion than those with
atrial fibrillation (42 6 19 vs. 28 6 15 cm/s [mean 6 SD], p <
0.001). Left atrial appendage shear rates were also higher in
patients with atrial flutter (103 6 82 vs. 59 6 37 s21, p < 0.001).
After cardioversion, left atrial appendage flow velocities decreased
compared with precardioversion values in patients with atrial
fibrillation (28 6 15 before to 15 6 14 cm/s after cardioversion,
p < 0.001) and atrial flutter (426 19 to 276 18 cm/s, respectively,
p < 0.001). Shear rates decreased from 59 6 37 before cardiover-
sion to 30 6 31 s21 after cardioversion in atrial fibrillation (p <
0.001), and from 103 6 82 s to 65 6 52 s21, respectively (p <
0.001), in atrial flutter. This decrease in flow velocity from before
to after cardioversion occurred in 36 (82%) of 44 patients with
atrial fibrillation and 14 (74%) of 19 with atrial flutter. The
impaired left atrial appendage function after cardioversion was
less pronounced in the group with atrial flutter (27 6 18 cm/s for
atrial flutter vs. 15 6 14 cm/s for atrial fibrillation, p < 0.001).
New or increased spontaneous echo contrast occurred in 22 (50%)
of 44 patients with atrial fibrillation versus 4 (21%) of 19 with
atrial flutter (p < 0.05).
Conclusions. Left atrial appendage stunning also occurs in
patients with atrial flutter, although to a lesser degree than in
those with atrial fibrillation. These data suggest that patients with
atrial flutter are at risk for thromboembolic events after cardio-
version, although this risk is most likely lower than that in
patients with atrial fibrillation because of better preserved left
atrial appendage function.
(J Am Coll Cardiol 1997;29:582–9)
q1997 by the American College of Cardiology
It is widely believed that patients with atrial flutter are less
susceptible to embolic complications of cardioversion than
those with atrial fibrillation. However, although some investi-
gators (1) have suggested that this is the result of a more
synchronous atrial activity during atrial flutter, the mechanism
of this reduced embolic risk is currently undefined. Left atrial
appendage stunning after electrical cardioversion of atrial
fibrillation has recently been proposed as a mechanism for
thromboembolism in the immediate postcardioversion period
(2). This stunning phenomenon has been demonstrated by
Doppler echocardiography to consist of impaired left atrial
appendage function and increased atrial spontaneous echo
contrast. The theoretic mechanism of postcardioversion
thrombogenesis has acquired support from a recent publica-
tion (3) that reported on embolic events in 17 patients with
negative results on a precardioversion transesophageal echo-
cardiographic examination for thrombus. Because a similar
mechanism for thromboembolic events in patients with atrial
flutter seems likely and, if established, could alter prevailing
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attitudes toward the susceptibility to thromboembolic compli-
cations of cardioversion (and in turn the need for anticoagu-
lation), we elected to study left atrial appendage function
before and after cardioversion in a group of patients with atrial
flutter and compared them with patients with atrial fibrillation,
using transesophageal Doppler echocardiography. The pur-
pose of this study was therefore threefold: 1) to determine
whether left atrial appendage stunning occurred in atrial
flutter; 2) to compare the magnitude of left atrial appendage
stunning in patients with atrial flutter with that in patients with
atrial fibrillation; and 3) to gain insight into the mechanism for
the reduced thromboembolic risk in atrial flutter versus fibril-
lation by analyzing left atrial appendage function.
Methods
Patients. We performed transesophageal Doppler echo-
cardiography before and after successful electrical cardiover-
sion in 63 patients with atrial fibrillation (n 5 44) and atrial
flutter (n 5 19) of at least 2 days in duration in whom a
transesophageal echocardiogram was requested to rule out the
presence of left atrial thrombi. All patients were enrolled and
studied before the initiation of the Assessment of Cardiover-
sion Utilizing Transesophageal Echocardiography (ACUTE)
trial (4), and therefore patient selection was not influenced by
this study recruitment. Informed consent was obtained before
the procedure, and the study was approved by the Institutional
Review Board of the Cleveland Clinic Foundation. Twenty of
these patients were part of the original series describing left
atrial appendage stunning in atrial fibrillation and have been
reported on previously (2). The presenting rhythm was con-
firmed by 12-lead electrocardiography before transesophageal
echocardiography. Patients found to have atrial thrombi de-
tected at the time of transesophageal echocardiography as well
as those with unsuccessful cardioversion were excluded from
the study. Transesophageal echocardiography was performed
using commercially available equipment (Hewlett-Packard So-
nos 1500 or 1000 or Acuson 128 XP/10) equipped with a
5-MHz phased array biplane transducer. All patients were
examined in a fully equipped electrophysiology laboratory.
After obtaining consent, 1% lidocaine viscous plus 1% ceto-
caine topical spray was used to anesthetize the oropharynx.
Patients were subsequently sedated using Versed (1 to 4 mg)
and Demerol (12.5 to 50 mg) intravenously as needed, after
which the transesophageal echocardiographic probe was in-
serted into the esophagus. After a complete transesophageal
echocardiographic examination, with special attention given to
left atrial and atrial appendage anatomy and function, patients
were anesthetized with brevitol (methohexital, 0.5 to 1.0 mg/kg
body weight), with the total duration of anesthesia lasting ;5
to 10 min. After ensuring adequate anesthesia, electrical
cardioversion was performed (5) using a Zoll device and
200 J of energy as the initial charge for patients with atrial
fibrillation and 100 J of energy for patients with atrial flutter.
Once successful cardioversion was achieved and cardiopulmo-
nary stability assumed, the transesophageal echocardiographic
probe was reinserted, and reexamination of the left atrial cavity
and appendage was performed. On completion of the echo-
cardiographic examination, each patient was monitored until
recovery from sedation and anesthesia was confirmed, and
patients were observed in the hospital until the following
morning.
Echocardiographic analysis. Left atrial cavity and append-
age anatomy and function were evaluated both before and
after electrical cardioversion, with special attention given to
identifying spontaneous echo contrast or thrombi, or both. Left
atrial appendage function was assessed before and after car-
dioversion using pulsed Doppler echocardiography by placing
the sample volume 1.5 cm into the mouth of the atrial
appendage in the basal transverse plane at the level of the
aortic valve. Peak flow velocities at end-diastole were mea-
sured and averaged over six cardiac cycles for patients in atrial
fibrillation and flutter before cardioversion and over three
cardiac cycles for all patients in sinus rhythm after cardiover-
sion. Left atrial appendage areas were measured by planim-
etry, and atrial appendage diameters were measured off-line in
the basal transverse plane. Diameters were obtained at the
level of the sample volume (1.5 cm into the mouth of the atrial
appendage) so as to obtain a radius measurement for the
calculation of shear rate.
Left atrial appendage shear rates were calculated using
peak velocity data (Vm) and left atrial appendage diameters
(LAAd) using a formula derived from Poiseuilles’ law. Assum-
ing a parabolic flow profile across the diameter of the left atrial
appendage (unpublished data), we estimated that shear rates
would be greatest along the periphery of the cavity. Therefore,
shear rates (SR) were calculated using the equation
SR5
23Vm
LAAd/2
.
Left atrial cavity function was assessed after cardioversion by
pulsed Doppler interrogation of mitral inflow (with the sample
volume placed at the leaflet tips) and measurement of the A
wave peak velocity. The mitral A wave velocities were then
averaged over three cardiac cycles.
Spontaneous echo contrast was defined as dynamic intracav-
itary echoes with a characteristic swirling pattern distinct from
white noise artifact. Gain settings were decreased in a stepwise
manner to exclude white noise artifact due to excessive gain.
These settings were adjusted for optimal visualization of
spontaneous echo contrast and maintained for the postcardio-
version study. The degree of spontaneous echo contrast was
categorized independently by two different observers (R.G.,
A.K.) as absent, mild or severe based on the system described
by Daniel et al. (6) and Beppu et al. (7).Mild spontaneous echo
contrast was defined as being present if dynamic intracavitary
microechoes were seen only with high gain, whereas severe
spontaneous echo contrast was present if spontaneous contrast
was noted with low gain. The detection and grading of
spontaneous echo contrast was reviewed before and after
cardioversion, on-line by two separate experienced echocar-
diographers (R.G., A.K.) who had no knowledge of the other
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interpretations. The determination of increased intensity or
the development of new smoke after cardioversion was made if
new spontaneous contrast was observed or if an increase from
mild to severe spontaneous contrast was agreed on by consen-
sus.
Determination of intraobserver and interobserver variation
in spontaneous contrast. The timing of the observation was
blinded only for the off-line analysis because blinding of the
precardioversion versus postcardioversion observation during
the on-line analysis was not possible. The results for the
interobserver and intraobserver variation for the detection of
left atrial spontaneous echo contrast were published previously
in a smaller group of patients and found to be 91% and 84%,
respectively (2).
Statistical methods. Dichotomous, ordinal and continuous
variables comprised the data set that was analyzed. The Fisher
exact test compared groups for dichotomous variables; the
Wilcoxon test analyzed ordinal variables; and the t test was
used for continuous variables. A repeated measures analysis of
variance with planned comparisons was used to analyze pre-
conversion with postconversion velocities and shear rates.
Logistic regression was performed to model the occurrence of
left atrial appendage stunning and the development of in-
creased spontaneous echo contrast. Analyses with p values
#0.05 were considered significant.
Results
Study group. We studied 63 consecutive patients with atrial
fibrillation (n5 44) and atrial flutter (n5 19) of at least 2 days
in duration undergoing transesophageal echocardiography be-
fore scheduled cardioversion. All patients had successful car-
dioversions as defined by the maintenance of sinus rhythm for
at least 24 h. Patients with atrial fibrillation and atrial flutter
were similar in mean age of 65 6 12 and 66 6 8 years,
respectively; however, duration of the arrhythmia was longer
for those with atrial fibrillation, although this difference was
not statistically significant (6.8 6 8.5 vs. 4.3 6 4.9 months for
atrial flutter, p 5 0.143). Suspected underlying etiologies for
the atrial arrhythmias included hypertension, valvular heart
disease, hypertrophic obstructive cardiomyopathy, dilated car-
diomyopathy, idiopathic and coronary artery disease. There
was a greater proportion of patients with valvular heart disease
and hypertrophic cardiomyopathy in the atrial fibrillation
group than in the atrial flutter group, whereas the atrial flutter
group had a greater proportion of patients with coronary artery
disease and dilated cardiomyopathy (Table 1). Left ventricular
function was similar in both groups: mean ejection fraction
53 6 16% (range 20% to 78%) versus 47 6 17% (range 15%
to 72%) for atrial fibrillation versus atrial flutter (p 5 0.141).
In reference to the cardioversion procedure itself, patients with
atrial fibrillation received higher energy levels (328 6 211 vs.
185 6 64 J, p , 0.001) as well as a greater number of total
shocks (1.5 6 0.6 vs. 1.1 6 0.3, p 5 0.017). At the completion
of a 4-week follow-up period, no thromboembolic events were
reported, although 42 (95%) of 44 patients with atrial fibrilla-
tion and 13 (68%) of 19 with atrial flutter were receiving
anticoagulation at the time of the cardioversion. In the atrial
fibrillation group, heparin was used in 11 of 44 patients,
warfarin in 31 of 44 and both heparin plus warfarin in 4 of 44
before and immediately after cardioversion. In the atrial flutter
group, heparin was used in 5 of 19 patients, warfarin in 8 of 19
and both heparin and warfarin in 1. Additionally, 11 patients
with atrial fibrillation had a previous cerebrovascular event,
whereas no patient with atrial flutter had such an event.
Before cardioversion. At the time of presentation to the
electrophysiology laboratory, patients with atrial flutter exhib-
ited greater left atrial appendage flow velocities than those
with atrial fibrillation (42 6 19 vs. 28 6 15 cm/s, p , 0.001).
Left atrial appendage shear rates were also higher in patients
with atrial flutter (103 6 82 vs. 59 6 37 s21, p , 0.001).
Spontaneous echo contrast was more prevalent in patients with
atrial fibrillation (80% vs. 42% in atrial flutter, p , 0.001), and
left atrial diameter was not significantly different between
groups. Although left atrial appendage area was larger in the
atrial fibrillation group, this difference was not significantly
different (6.9 6 2.8 vs. 5.9 6 1.7 cm2, p 5 0.105).
After cardioversion. After cardioversion, left atrial ap-
pendage flow velocities (Fig. 1) and shear rates (Fig. 2)
decreased compared with precardioversion values in patients
with atrial fibrillation as well as atrial flutter. In atrial fibrilla-
tion, the average flow velocities decreased from 286 15 before
to 15 6 14 cm/s after cardioversion (p , 0.001), whereas shear
rates decreased from 59 6 37 to 30 6 31 s21, respectively (p ,
0.001). Left atrial appendage stunning, which was defined as a
Table 1. Clinical and Echocardiographic Characteristics of
Patients With Atrial Fibrillation or Atrial Flutter Undergoing
Electrical Cardioversion
Atrial
Fibrillation
(n 5 44)
Atrial
Flutter
(n 5 19) p Value
Age (yr) 65 6 12 66 6 8 0.546
Male/female 14/30 9/10 0.250
AF duration (mo) 6.8 6 8.5 4.3 6 4.9 0.143
$ moderate MR 4 1 1.000
LVEF (%) 53 6 16 47 6 17 0.141
LVEDD (mm) 54 6 11 56 6 11 0.405
LVESD (mm) 37 6 13 41 6 13 0.22
LA size (mm) 50.1 6 6.9 48.5 6 4.9 0.37
LAA area (cm2) 6.9 6 2.8 5.9 6 1.7 0.105
Heart rate (beats/min) 95 6 21 98 6 27 0.640
Hypertension 13 (30%) 5 (26%) 0.792
Valvular disease 13 (30%) 3 (16%) 0.204
ASHD 4 (9%) 6 (32%) 0.051
HOCM 6 (14%) 0 (0%) 0.008
Idiopathic 5 (11%) 2 (11%) 0.922
DCM 3 (7%) 3 (16%) 0.329
Data presented are mean value6 SD or number (%) of patients. AF5 atrial
fibrillation; ASHD 5 atherosclerotic heart disease; DCM 5 dilated cardiomy-
opathy; HOCM 5 hypertrophic obstructive cardiomyopathy; LA 5 left atrial;
LAA 5 left atrial appendage; LVEDD 5 left ventricular end-diastolic dimen-
sion; LVEF 5 left ventricular ejection fraction; LVESD 5 left ventricular
end-systolic dimension; MR 5 mitral regurgitation.
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decrease in flow velocity from before to after cardioversion of
at least 20%, occurred in 36 (82%) of 44 patients with atrial
fibrillation (Fig. 3). In atrial flutter, left atrial appendage
function also exhibited a decrease in flow velocity from before
to after cardioversion (Fig. 4). During atrial flutter, flow
velocities averaged 42 6 19 cm/s; after conversion to sinus
rhythm, flow velocities decreased to 27 6 18 cm/s (p , 0.001).
Shear rates also decreased in patients with atrial flutter from
103 6 82 s21 before to 65 6 52 s21 after conversion (p ,
0.001). Overall, this stunning phenomenon was observed in 14
(74%) of 19 patients with pure atrial flutter (Fig. 3) and 5 of 7
patients with atrial flutter with no history of previous atrial
fibrillation. Moreover, absolute left atrial appendage function
after cardioversion was less depressed in the group with atrial
flutter because left atrial appendage velocities were signifi-
cantly greater in the atrial flutter group after cardioversion at
27 6 18 cm/s than after cardioversion in the atrial fibrillation
group with a mean velocity of 15 6 14 cm/s (p , 0.001). The
higher left atrial appendage velocities after cardioversion of
atrial flutter were observed despite the finding of similar
absolute differences in flow velocities from before to after
cardioversion (14 6 13 cm/s for atrial fibrillation, 17 6 15 cm/s
for atrial flutter, p 5 0.757). This observation can therefore
best be explained by the higher left atrial appendage velocities
in patients with atrial flutter before cardioversion than in those
with atrial fibrillation (Fig. 1), as opposed to a more significant
stunning effect in patients with atrial fibrillation. Furthermore,
left atrial cavity function after cardioversion exhibited better
contractility during flutter than atrial fibrillation because mitral
inflow A wave velocities after cardioversion were significantly
higher in the group with atrial flutter (366 24 cm/s) than in the
group previously in atrial fibrillation (226 17 cm/s, p5 0.029).
Left atrial spontaneous echo contrast. Before undergoing
cardioversion, 35 (80%) of 44 patients with atrial fibrillation
were found to have spontaneous echo contrast compared with
only 8 (42%) of 19 with atrial flutter (p , 0.002). After
electrical cardioversion, new or increased spontaneous con-
trast was detected in 22 (50%) of the 44 patients with atrial
fibrillation versus only 4 (21%) of 19 with atrial flutter (p 5
0.032) (Fig. 5).
Predictors of left atrial appendage stunning and increased
spontaneous contrast. Stepwise logistic regression analysis
was performed in an attempt to identify potential clinical or
echocardiographic predictors of new spontaneous echo con-
trast or left atrial appendage stunning. Precardioversion clini-
cal and echocardiographic variables significant at the 0.2 level
by univariate analysis were included, and all models included
age, gender, rhythm and left atrial size as confounders. The
only significant predictor for new spontaneous echo contrast
after cardioversion was atrial fibrillation because patients with
atrial fibrillation were 4.7 times more likely to have increased
spontaneous echo contrast than those with atrial flutter (95%
confidence interval 1.3 to 17.6, p 5 0.021). The logistic
regression model using precardioversion variables did not
identify any significant variables for predicting left atrial
appendage stunning.
Discussion
Previous investigation from our laboratory (2) demon-
strated the phenomenon of left atrial appendage stunning as a
mechanism by which de novo thrombogenesis and subsequent
thromboembolism could result after the successful electrical
cardioversion of patients with atrial fibrillation. The present
study confirms this finding in a larger group of patients in
addition to elucidating similar but importantly different mech-
anistic information regarding patients with atrial flutter. In the
present study, patients with atrial flutter also exhibited left
atrial appendage stunning after cardioversion, although the
Figure 1. Left atrial appendage (LAA) flow velocity changes between
atrial fibrillation (solid bars) and atrial (open bars) flutter before and
after cardioversion. Left atrial appendage velocity decreased from
before to after cardioversion in patients with atrial fibrillation and
atrial flutter. Significant differences (p, 0.001) in left atrial appendage
flow velocities are also observed between atrial fibrillation and atrial
flutter, both before as well as after cardioversion.
Figure 2. Effect of electrical cardioversion on left atrial appendage
(LAA) shear forces between atrial fibrillation (solid bars) and atrial
flutter (open bars) before and after cardioversion. Left atrial append-
age shear rate decreased from before to after cardioversion in patients
with atrial fibrillation and atrial flutter. Significant differences (p ,
0.001) in left atrial appendage shear rates are also observed between
atrial fibrillation and atrial flutter, both before as well as after
cardioversion.
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stunning phenomenon was significantly less pronounced than
in those with atrial fibrillation. Additionally, postcardioversion
left atrial appendage function is better preserved, in terms of
flow velocities, in atrial flutter than in atrial fibrillation. Finally,
some patients with atrial flutter also demonstrated increased
spontaneous echo contrast immediately after cardioversion.
However, this finding of increased spontaneous echo contrast
was observed at a markedly reduced frequency in patients with
Figure 3. Effect of electrical cardioversion on left atrial ap-
pendage (LAA) flow velocity in patients with atrial fibrillation
(AF) (left) and atrial flutter (AFL) (right) before (Pre) and
after (Post) cardioversion. Vertical bars 5 mean value 6 SD.
Figure 4. Representative left atrial appendage
pulsed Doppler flows illustrating the “stunning”
phenomenon after electrical cardioversion in a
patient with atrial flutter. Left atrial appendage
flow in atrial flutter before cardioversion (top)
with “flutter waves” on the electrocardio-
graphic tracing preceding each forward and
reverse Doppler flow and left atrial appendage
flow in sinus rhythm after cardioversion (bot-
tom) with a p wave preceding the late diastolic
forward and reverse flow. paper speed 5
50 mm/s.
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atrial flutter than in those with atrial fibrillation. These results
provide the first mechanistic support for historical data that
suggest that patients with atrial flutter are less likely than those
with atrial fibrillation (yet still prone) to experience thrombo-
embolic complications after cardioversion.
Published reports to date on the cardioversion of atrial
flutter strongly suggest that these patients are at a very low risk
of thromboembolic events before and after cardioversion;
hence the rationale of many physicians for avoiding the use of
anticoagulation in patients with atrial flutter as well as the
somewhat arbitrary tone of the current anticoagulation guide-
lines that advocate anticoagulation for atrial flutter solely in
the presence of a history of fibrillation. However, review of the
published reports reveals that relatively few patients with atrial
flutter have been carefully studied. In 1965, Jensen et al. (8)
studied 50 patients undergoing electrical cardioversion, 7 of
whom were in atrial flutter, with no embolic events detected in
either group. Two years later, Wikland et al. (9) reported on 74
patients undergoing electrical cardioversion, with 8 of the
patients in atrial flutter. One mesenteric embolic event was
reported; however, the underlying rhythm in this patient was
not revealed. Fritz and Aberg (10) reported on 29 patients with
atrial flutter undergoing electrical cardioversion in 1970, none
of whom sustained an embolic event. Roy et al. (11) reported
embolic events in 2 of 30 patients with atrial flutter, both of
whom were not receiving anticoagulation at the time of
cardioversion. Arnold et al. (12), from our institution, retro-
spectively evaluated 122 patients with atrial flutter of 454
undergoing electrical cardioversion. No embolic events were
detected regardless of anticoagulation status. More recently,
Pagadala et al. (13) reported a 9% incidence of thromboem-
bolic events among 85 patients with atrial flutter, many of
whom had a history of atrial fibrillation. Other investigators
have combined patients with atrial flutter with those in atrial
fibrillation in studies on outcomes after cardioversion; how-
ever, details regarding the exact numbers of patients in atrial
flutter and a breakdown of event rates in flutter versus
fibrillation are often omitted in these reports (14–17).
Similar to the paucity of data on thromboembolism after
cardioversion of atrial flutter, few data exist on the prevalence
of intraatrial thrombus and the risk for thromboembolism in
atrial flutter. However, the prevailing notion has been to
assume that intraatrial thrombus is a rare phenomenon. A
recent study by Bikkina et al. (18) challenges traditional
thinking and provides some interesting insight into this area of
study. These investigators demonstrated a surprisingly high
incidence of atrial thrombus in a group of 24 consecutive
patients with atrial flutter admitted to the hospital. Intraatrial
thrombus was detected by transesophageal echocardiography
in 5 (21%) of 24 patients with atrial flutter versus 6 (3%) of 184
in a control group. Predictors of the presence of thrombus in
this cohort included male gender, ejection fraction ,40% and
atrial flutter. Therefore, it would appear from this isolated
report that the potential for thrombogenesis in atrial flutter
may have been underestimated in the past.
Support for left atrial appendage stunning as a mechanism
for thromboembolic events. Clinical evidence supporting left
atrial appendage stunning and postcardioversion thrombogen-
esis was provided by Black et al. (3) who described 17 patients
with atrial fibrillation and sustained thromboembolic events
after cardioversion despite a transesophageal echocardiogram
that demonstrated no evidence for thrombus. In a smaller
series of patients with atrial flutter studied by Baruch et al.
(19), two embolic events were observed after cardioversion,
again despite a transesophageal echocardiogram that was
negative for the presence of thrombus. Contrary to the tradi-
tionally described etiologic mechanism for thromboembolic
events after cardioversion, as first proposed by Goldman et al.
(20), that suggested that preexisting thrombus was the sole
etiology of thromboembolic events, these more recent data
(3,19) support postcardioversion thrombogenesis as a more
important pathophysiologic mechanism than previously recog-
nized. Furthermore, the physiologic data presented in our
study suggest that left atrial appendage stunning is a likely
mechanism for the observed thromboembolic episodes after
cardioversion, as described in patients with atrial fibrillation as
well as in those with atrial flutter. One might also argue that
the high incidence of atrial appendage stunning and increase
in spontaneous echo contrast intensity in both groups could
be an argument against atrial stunning as a mechanism of
Figure 5. Frequency of new or increased spontaneous echo
contrast (SEC), or both, after cardioversion in patients with atrial
fibrillation (left) and atrial flutter (right). New or increased
spontaneous contrast was detected in 22 (50%) of the 44 patients
with atrial fibrillation versus only 4 (21%) of 19 with atrial flutter
(p 5 0.032).
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thromboembolic events given the rather low event rate of
cardioversion-related embolic events of ;1.6%. However,
these observations simply highlight circumstances (i.e., atrial
appendage stunning) that appear to provide a mileu for
thrombogenesis because frank thrombus was never identified,
and anticoagulation was present in 95% and 68% of patients
with atrial fibrillation and atrial flutter, respectively.
Because all patients included in the present study under-
went electrical cardioversion, the question regarding the po-
tential role of the electrical energy in the development of atrial
appendage stunning requires discussion. Previous investiga-
tions implicated the electrical energy as the cause for atrial
stunning (2,21); however, recent evidence (22) suggests that
left atrial appendage stunning can be seen independent of the
application of electrical energy. In the present study, two
patients undergoing transesophageal echocardiography con-
verted to sinus rhythm spontaneously during the transesopha-
geal examination and demonstrated left atrial appendage
stunning despite the absence of antiarrhythmic drugs or an
electric shock. One of the patients was in atrial fibrillation and
the other in atrial flutter. Furthermore, others investigators
(23) have demonstrated that patients examined by transesoph-
ageal echocardiography before and after failed attempts at
cardioversion of atrial fibrillation did not exhibit diminished
fibrillatory flow velocities after the electric shock. Although it
is possible that the electrical energy contributes to the atrial
appendage stunning, these recent studies would suggest that it
is unlikely to be the etiologic mechanism for this phenomenon.
Clinical implications. Current recommendations by the
American College of Chest Physicians (1) with regard to
anticoagulation for patients with atrial flutter in the pericar-
dioversion period, suggest that anticoagulation is not required
for patients with atrial flutter unless the patient has had a
previous history of atrial fibrillation. The data presented in the
present study demonstrate that the left atrial appendage
stunning phenomenon occurred in atrial flutter, independent
of a previous history of atrial fibrillation, suggesting that the
possibility of postcardioversion thrombogenesis exists regard-
less of previous history of fibrillation. Although the existence
of left atrial appendage stunning implies that all patients with
atrial flutter are at a potential risk for thromboembolic events
and therefore should be undergo anticoagulation (similar to
those with atrial fibrillation), the duration of anticoagulation
required after the procedure is likely to be significantly shorter
than that required for atrial fibrillation. The basis for this
hypothesis is that the return of left atrial appendage function
after conversion to normal values is likely to be more rapid in
atrial flutter than in atrial fibrillation. Return of left atrial
appendage function beyond the immediate postcardioversion
period was not examined in the present study, and therefore
the time course for return to normal function remains un-
known, hence a limitation of the current study. Manning et al.
(24), studied the return of atrial cavity function in patients with
acute and chronic atrial fibrillation by transthoracic echocar-
diography and demonstrated that mitral A wave inflow veloc-
ities return to near normal values earlier in patients with acute
than in those with chronic atrial fibrillation. They therefore
suggested that the required duration of anticoagulation after
cardioversion is shorter in patients with acute versus chronic
atrial fibrillation. For example, patients with acute atrial
fibrillation and otherwise normal hearts may require anticoag-
ulation for only 1 week after cardioversion, whereas those with
chronic atrial fibrillation may need a full 4 weeks of anticoag-
ulation because atrial function may not fully return to normal
until the fourth week. Other factors, in addition to chronicity,
are likely to affect the degree and duration of left atrial
appendage stunning, such as the underlying pathology, left
atrial size and left ventricular function. Unfortunately, the
limited sample size in the study by Manning et al. (24) and the
lack of long-term follow-up in our study preclude such risk
stratification at the present time. Clearly, further investigation
regarding return of left atrial appendage function after cardio-
version is imperative to provide data to support tailoring the
duration of anticoagulation therapy after cardioversion in
patients with atrial fibrillation and atrial flutter.
Role of echocardiography in patients with atrial flutter
undergoing cardioversion. Similar to its role in patients with
atrial fibrillation (25), the utility of transesophageal echocar-
diography in patients with atrial flutter is dependent on the
need to rule in or rule out the presence of thrombus. Because
of the existence of atrial appendage stunning in atrial flutter,
the exclusion of a thrombus before cardioversion does not
obviate the need for anticoagulation after cardioversion
(2,3,25), although it should lower the risk of cardioversion as
one of the two potential mechanisms for thromboembolic
events after cardioversion is excluded. Additionally, utilization
of transesophageal echocardiography may allow earlier cardio-
version and the avoidance of 3 to 4 weeks of anticoagulation
before cardioversion (25,26).
Conclusions. The phenomenon of left atrial appendage
stunning and the development of new or increased left atrial
spontaneous echo contrast previously reported for patients
with atrial fibrillation undergoing cardioversion also occur in
patients with atrial flutter. These data suggest that the poten-
tial for the development of a thrombogenic milieu does exist in
patients with atrial flutter as a result of left atrial appendage
stunning, and therefore these patients should not be consid-
ered risk free for thromboembolic events after cardioversion.
However, the likelihood of this embolic risk is probably
significantly lower than that in patients with atrial fibrillation
because of the attenuated degree of left atrial appendage stun-
ning in atrial flutter compared with that in atrial fibrillation.
We thank the staff of the section of electrophysiology at the Cleveland Clinic for
their support and assistance in patient recruitment.
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